Causes of albuminocytological dissociation and the impact of age-adjusted cerebrospinal fluid protein reference intervals: a retrospective chart review of 2627 samples collected at tertiary care centre.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
13 02 2019
Historique:
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 28 3 2020
Statut: epublish

Résumé

We set out to test the discriminative power of an age-adjusted upper reference limit for cerebrospinal fluid total protein (CSF-TP) in identifying clinically relevant causes of albuminocytological dissociation (ACD). We reviewed the charts of 2627 patients who underwent a lumbar puncture at a tertiary care centre over a 20-year period. Samples with CSF-TP above 45 mg/dL (0.45 g/L) were included. Samples with white cell count >5×10 The presence of ACD was associated with a broad range of neurological diagnoses. Among all 2627 patients with ACD, a clinical diagnosis explaining CSF-TP elevation was identified in 57% of cases. 'True' ACD was associated with a suitable diagnosis in 75% of cases, whereas patients with 'pseudo' ACD showed an appropriate diagnosis in only 51% of cases. Use of an age-adjusted upper reference limit favoured the detection of polyneuropathy patients (13.5% proportionate increase) and excluded a larger number of patients with isolated headache (10.7% proportionate decrease; p<0.0001). Elevated CSF-TP is a common finding, with a range of underlying causes. Use of an age-adjusted upper reference limit for the CSF-TP value improves diagnostic specificity and helps to avoid overdiagnosis of ACD.

Identifiants

pubmed: 30765408
pii: bmjopen-2018-025348
doi: 10.1136/bmjopen-2018-025348
pmc: PMC6398735
doi:

Substances chimiques

Blood Glucose 0
Cerebrospinal Fluid Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e025348

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Epileptic Disord. 2015 Dec;17(4):453-9
pubmed: 26575850
Rass Neuropsichiatr. 1951 Sep-Oct;5(5):305-28
pubmed: 14912484
Eur J Neurol. 2006 Sep;13(9):913-22
pubmed: 16930354
Stroke. 1975 Nov-Dec;6(6):638-41
pubmed: 1198628
Bull Soc Ophtalmol Fr. 1971 May-Jun;71(5-6):637-41
pubmed: 5317158
BMC Res Notes. 2016 Feb 15;9:95
pubmed: 26879928
J Neurol. 2002 Aug;249(8):1021-6
pubmed: 12195448
Arq Neuropsiquiatr. 1995 Mar;53(1):69-74
pubmed: 7575211
Neurology. 1996 Feb;46(2):368-72
pubmed: 8614496
J Med Toxicol. 2012 Jun;8(2):124-9
pubmed: 22090149
Spine (Phila Pa 1976). 2002 Aug 1;27(15):E356-60
pubmed: 12163736
Clin Chem. 2017 Dec;63(12):1856-1865
pubmed: 29021324
Klin Med (Mosk). 1990 Dec;68(12):60-2
pubmed: 2084346
Rev Soc Bras Med Trop. 2011 Nov-Dec;44(6):787-8
pubmed: 22231257
J Neurol. 1982;228(3):171-80
pubmed: 6186790
J Int Med Res. 2009 Nov-Dec;37(6):1913-20
pubmed: 20146891
J Korean Neurosurg Soc. 2016 Nov;59(6):570-576
pubmed: 27847569
Brain. 2000 Jul;123 ( Pt 7):1481-94
pubmed: 10869059
J Neurol. 2005 Sep;252(9):1067-73
pubmed: 15789126
Clin Rheumatol. 2014 Jan;33(1):105-10
pubmed: 24096639
Clin Chem Lab Med. 2016 Feb;54(2):285-92
pubmed: 26079822
Neurology. 2004 Nov 23;63(10):1966-7
pubmed: 15557527
Mult Scler. 2012 Aug;18(8):1081-91
pubmed: 22252467
Neuroradiology. 2005 May;47(5):344-51
pubmed: 15887011
Exp Ther Med. 2012 Nov;4(5):923-927
pubmed: 23226750
Neurology. 2015 Aug 11;85(6):498-504
pubmed: 26180143
J Neurol Sci. 1981 Feb;49(2):293-303
pubmed: 7217986
Rinsho Shinkeigaku. 2015;55(8):550-4
pubmed: 26211664
Stroke. 1990 Feb;21(2):348-56
pubmed: 2406996
Ann Med Interne (Paris). 1999 Jan;150(1):24-32
pubmed: 10400560
Arq Neuropsiquiatr. 2016 Jun;74(6):501-12
pubmed: 27332077
Vaccine. 2011 Dec 6;29(52):9697-701
pubmed: 22001121
Spine J. 2009 Jul;9(7):545-50
pubmed: 19398386
Front Neurol. 2017 Jul 26;8:368
pubmed: 28798722
Chin Med J (Engl). 2001 Jul;114(7):764-6
pubmed: 11780346
Cerebrospinal Fluid Res. 2008 Apr 25;5:9
pubmed: 18439296
J Med Lyon. 1968 Oct 5;49(150):1479-88
pubmed: 5738897
Arch Neurol. 2005 Jun;62(6):865-70
pubmed: 15956157
Handb Clin Neurol. 2017;146:125-138
pubmed: 29110767
Mayo Clin Proc. 2015 Oct;90(10):1366-71
pubmed: 26349950

Auteurs

John Alexander Brooks (JA)

Department of Medicine, Division of Neurology, University of Ottawa, Ottawa, Ontario, Canada.

Christopher McCudden (C)

Department of Pathology and Laboratory Medicine, Division of Biochemistry, University of Ottawa, Ottawa, Ontario, Canada.

Ari Breiner (A)

Department of Medicine, Division of Neurology, University of Ottawa, Ottawa, Ontario, Canada.
The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Pierre R Bourque (PR)

Department of Medicine, Division of Neurology, University of Ottawa, Ottawa, Ontario, Canada.
The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH